Loading...
Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial
AIMS: Thiazolidinediones are insulin sensitizers, and are associated with fluid retention and increased risk of heart failure (HF) in people with type 2 diabetes. We assessed fatal and non-fatal HF events and their outcome, and identified HF predictors in the RECORD (Rosiglitazone Evaluated for Card...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2848325/ https://ncbi.nlm.nih.gov/pubmed/20118174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehp604 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|